---
title: 'Mesenchymal stromal cell chondrogenesis under ALK1/2/3-specific BMP inhibition:
  a revision of the prohypertrophic signalling network concept'
date: '2024-04-05'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38581019/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240406181050&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSIONS: Overall, our data show that BMP-ALK1/2/3 inhibition cannot
  program mesenchymal stromal cells toward stable chondrogenesis. BMP-ALK1/2/3 signalling
  is no driver of hypertrophic MSC misdifferentiation and BMP receptor induction is
  not an adverse prohypertrophic side effect of TGF-β that leads to endochondral MSC
  misdifferentiation. Instead, the prohypertrophic network comprises misregulated
  PTHrP/hedgehog signalling and WNT activity, and a potential contribution ...'
disable_comments: true
---
CONCLUSIONS: Overall, our data show that BMP-ALK1/2/3 inhibition cannot program mesenchymal stromal cells toward stable chondrogenesis. BMP-ALK1/2/3 signalling is no driver of hypertrophic MSC misdifferentiation and BMP receptor induction is not an adverse prohypertrophic side effect of TGF-β that leads to endochondral MSC misdifferentiation. Instead, the prohypertrophic network comprises misregulated PTHrP/hedgehog signalling and WNT activity, and a potential contribution ...